Minimally invasive surgery may offer new option for severe Raynaud’s, doctors report

Doctors in China have reported a promising use of a minimally invasive surgical technique to treat severe Raynaud’s phenomenon after a case in which the procedure appeared to restore blood flow and stop progression of gangrene in a patient’s fingers.

Physicians at Yubei District People’s Hospital described treating a 67-year-old woman who had a 10-year history of Raynaud’s and was admitted when the condition worsened, leading to gangrene of her right index and middle fingers. The team said they performed a targeted, minimally invasive operation to re-establish circulation to the affected digits; following the procedure the patient’s wounds stabilized and no further tissue loss was reported during follow-up.

Raynaud’s phenomenon is a common circulatory disorder in which small arteries that supply blood to the skin constrict excessively in response to cold or stress, temporarily cutting off blood flow to the fingers, toes, ears or nose. Estimates suggest the condition affects as many as 5 percent of adults worldwide — including up to 30 million people in the United States — and can cause numbness, color changes and pain. In severe cases, persistent lack of blood flow can lead to painful sores, infections or tissue death (gangrene).

There is no widely accepted cure for Raynaud’s, and management typically focuses on lifestyle measures such as keeping extremities warm and avoiding triggers, along with medications to dilate blood vessels in patients with more significant symptoms. Surgical options, including various forms of sympathectomy, have been used in select severe cases to interrupt the nerves that trigger vessel constriction, but they are not standard therapy and carry risks.

In the reported case, hospital doctors described using a less invasive surgical approach aimed at improving digital perfusion. The operation was followed by clinical improvement, according to the report, and the medical team said the intervention appeared to halt the progression of gangrene that had threatened the patient’s digits.

The authors of the case report framed their findings as preliminary and called for further investigation to determine whether the technique can be replicated safely and effectively in larger groups of patients. Single-case reports cannot establish the overall safety profile or long-term benefit of a procedure, and physicians caution that outcomes may differ by patient and by underlying causes of Raynaud’s.

Raynaud’s can occur on its own (primary Raynaud’s) or as part of another disease, such as autoimmune connective-tissue disorders (secondary Raynaud’s), and treatment decisions often depend on the severity of symptoms and whether tissue damage is present. For patients with ulcers or gangrene, more aggressive interventions to restore blood flow and prevent infection are sometimes necessary.

Experts in vascular medicine and surgery typically recommend a stepwise approach, reserving invasive procedures for patients who do not respond to conservative measures and who face a risk of tissue loss. The newly reported case adds to a small but growing body of literature exploring targeted surgical options for severe Raynaud’s, but clinicians and researchers say randomized studies and longer-term follow-up will be needed to clarify which patients might benefit and to compare risks and outcomes against existing therapies.

Until more evidence is available, physicians advise patients with Raynaud’s, especially those experiencing persistent ulcers, discoloration or pain, to seek prompt medical evaluation to identify underlying causes and to discuss appropriate treatment strategies aimed at preventing complications.